Medicina
Department
Instituto de Investigación Sanitaria Aragón
Zaragoza, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria Aragón (22)
2024
-
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors
Journal of Hepatology, Vol. 80, Núm. 6, pp. 904-912
-
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211
-
Risk factors for suicide reattempt: A systematic review and meta-analysis
Psychological Medicine, Vol. 54, Núm. 9, pp. 1897-1904
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis
Acta Psychiatrica Scandinavica
-
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study
European Neuropsychopharmacology, Vol. 67, pp. 53-65
-
Risk of suicide attempt repetition after an index attempt: A systematic review and meta-analysis
General Hospital Psychiatry, Vol. 81, pp. 51-56
-
Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120
-
The polygenic basis of relapse after a first episode of schizophrenia
European Neuropsychopharmacology, Vol. 75, pp. 80-92
2022
-
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis
Schizophrenia, Vol. 8, Núm. 1
-
Epigenetic clocks in relapse after a first episode of schizophrenia
Schizophrenia, Vol. 8, Núm. 1
-
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
Schizophrenia, Vol. 8, Núm. 1
2021
-
A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood
Translational Psychiatry, Vol. 11, Núm. 1
-
DD04107-Derived neuronal exocytosis inhibitor peptides: Evidences for synaptotagmin-1 as a putative target
Bioorganic Chemistry, Vol. 115
-
Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis
Schizophrenia Research, Vol. 236, pp. 19-28
-
SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases
Open Respiratory Archives, Vol. 3, Núm. 2
2018
-
Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis
International Journal of Neuropsychopharmacology, Vol. 21, Núm. 5, pp. 410-422
-
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256
-
Smoking does not impact social and non-social cognition in patients with first episode psychosis
Schizophrenia Research, Vol. 199, pp. 64-74